Brief: TetraLogic Pharmaceuticals entered into sales agreement with Guggenheim Securities
13/03/2015 21:23
March 13 (Reuters) - TetraLogic Pharmaceuticals Corp TLOG.O : * Says on March 13, 2015, co entered into a sales agreement with guggenheim securities * Under agreement co to sell shares of common stock, par value $0.0001 per share, having aggregate price of up to $25 million * Source text for Eikon ID:nEOL4TPXgm * Further company coverage TLOG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Tetralogic Pharmaceuticals
See all newsNewscasts - Grieving father buries son killed by toxic cough syrup in India
Cellect: Soars on merger deal with Quoin Pharmaceuticals
Brief: Tetralogic announces pacts to restructure convertible debt
Brief: Tetralogic Pharmaceuticals says Pete Meyers resigned as CFO
Brief: TetraLogic Pharmaceuticals says birinapant shows no activity in randomized phase 2 mds study